Clinical trial
Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild…
NCT00367094 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00367094 |
|---|---|
| Title | Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension |
| Official title | Efficacy and Safety of the Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Benazepril |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Benazepril plus hydrochlorothiazide |
| Enrollment | 296 |
| Start date | Jul 1, 2006 |
| First posted | Aug 22, 2006 |
| Last update posted | Jul 9, 2007 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: